Clinical Trial Update: A Safety Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor [Phase 1]

View source ↗

Summary

Phase 1 safety study of STSP-0601 in adults with Hemophilia A or Hemophilia B with inhibitors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• STSP-0601 (STSP-0601)

Snippet

Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd | Conditions: Hemophilia | Phase 1 | Status: COMPLETED